Deubiquitinase USP1 Influences the Dedifferentiation of Mouse Pancreatic β-cells
Overview
Authors
Affiliations
Loss of insulin-secreting β-cells in diabetes may be either due to apoptosis or dedifferentiation of β-cell mass. The ubiquitin-proteasome system comprising E3 ligase and deubiquitinases (DUBs) controls several aspects of β-cell functions. In this study, screening for key DUBs identified USP1 to be specifically involved in dedifferentiation process. Inhibition of USP1 either by genetic intervention or small-molecule inhibitor ML323 restored epithelial phenotype of β-cells, but not with inhibition of other DUBs. In absence of dedifferentiation cues, overexpression of USP1 was sufficient to induce dedifferentiation in β-cells; mechanistic insight showed USP1 to mediate its effect via modulating the expression of inhibitor of differentiation (ID) 2. In an streptozotocin (STZ)-induced dedifferentiation mouse model system, administering ML323 alleviated hyperglycemic state. Overall, this study identifies USP1 to be involved in dedifferentiation of β-cells and its inhibition may have a therapeutic application of reducing β-cell loss during diabetes.
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.
Gojani E, Rai S, Norouzkhani F, Shujat S, Wang B, Li D Curr Issues Mol Biol. 2024; 46(7):7621-7667.
PMID: 39057094 PMC: 11275945. DOI: 10.3390/cimb46070453.
Chernysheva M, Ruchko E, Karimova M, Vorotelyak E, Vasiliev A Front Cell Dev Biol. 2024; 12:1424278.
PMID: 39045459 PMC: 11263198. DOI: 10.3389/fcell.2024.1424278.